Human C-reactive Protein Instant ELISA

Also known as: C reactive protein, pentraxin related, PTX1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS288INST*

Cat. No.	Size
BMS288INST	128 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Click on image to view more information.

Description

Description: The human C-reactive protein Instant ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human C-reactive protein. The human C-reactive protein Instant ELISA is for research use only. Not for diagnostic or therapeutic procedures.

C-reactive protein is an acute phase protein exclusively synthesized by hepatocytes in response to cytokines released into circulation by activated leukocytes. Serum and plasma levels of CRP have been shown to rise during response to a wide variety of diseases including bacterial infections, acute phase of rheumatoid arthritis, inflammation of the bile duct. High CRP is also found in Guillain-Barre syndrome patients, in multiple sclerosis, viral infections, tuberculosis, acute infectious hepatitis, necrotic diseases, burned patients and after surgical trauma.

CRP thus has been shown to be a useful indicator of inflammatory processes. CRP levels rise in serum or plasma within 24 to 48 hours after acute tissue damage, peaking at acute stage and decreasing with resolution of inflammation or trauma. In addition to being a marker of inflammatory diseases, CRP turned out to be a predictive value as cardiac marker to assess risk of cardio vascular and peripheral vascular disease.

Details

Reactivity	Human
Sample Volume	100 uL (1:500 prediluted)
Suitable Sample Types	cell culture supernatant, serum, plasma (EDTA, citrate, heparin)
Sensitivity	3.0 pg/mL
Standard Curve Range	78 - 5,000 pg/mL
Components	Aluminium pouch(es) with a Microwell Plate coated with Polyclonal Antibody (murine) to human C-reactive protein, HRP-Conjugate (anti human C-reactive protein monoclonal (murine) antibody) and Assay Buffer, lyophilized Aluminium pouch(es) with a human C-reactive protein Standard curve (coloured) Wash Buffer Concentrate 20x (phosphate-buffered saline with 1% Tween 20) Substrate Solution (tetramethyl-benzidine) Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA) Stop Solution (1M Phosphoric acid) Adhesive Plate Covers
Reported Applications	ELISA

Documentation

TDS Link	Download TDS

Related Products

Cat. No.	Name	Application	Reg.
BMS213HS*	Human IL-6 High Sensitivity ELISA	ELISA	RUO
BMS810FF*	Human Th1/Th2 11plex FlowCytomix Multiplex	Multiplex	RUO
BMS811/2FF*	Human Cardiovascular 6plex FlowCytomix Multiplex	Multiplex	RUO
BMS813FF*	Human Chemokine 6plex FlowCytomix Multiplex	Multiplex	RUO

References

Citations: Cesari,Matteo; Onder,Graziano; Zamboni,Valentina; Manini,Todd; Shorr,Ronald I.; Russo,Andrea; Bernabei,Roberto; Pahor,Marco; Landi,Francesco. Physical function and self-rated health status as predictors of mortality: results from longitudinal analysis in the ilSIRENTE study. BMC Geriatrics 2008;8:34(Link)

Haider,D.G.; Leuchten,N.; Schaller,G.; Gouya,G.; Kolodjaschna,J.; Schmetterer,L.; Kapiotis,S.; Wolzt,M.. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clinical & Experimental Immunology 2006;146:533-539. (Link)

Memoli,Bruno; Procino,Alfredo; Calabro,Paolo; Esposito,Pasquale; Grandaliano,Giuseppe; Pertosa,Giovanni; Prete,Marco Del; Andreucci,Michele; Lillo,Saverio Di; Ferulano,Giuseppe; Cillo,Clemente; Savastano,Silvia; Colao,Annamaria; Guida,Brunella. Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Endocrinology and Metabolism 2007;293:E1030-E1035. (Link)

Onder,Graziano; Liperoti,Rossella; Russo,Andrea; Soldato,Manuel; Capoluongo,Ettore; Volpato,Stefano; Cesari,Matteo; Ameglio,Franco; Bernabei,Roberto; Landi,Francesco. Body mass index, free Insulin Growth Factor 1 and physical function among older adults: results from the IlSIRENTE study. Endocrinology and Metabolism 2006;291:00138(Link)

Gurbel,Paul A.; Bliden,Kevin P.; Tantry,Udaya S.. Effect of Clopidogrel With and Without Eptifibatide on Tumor Necrosis Factor-Alpha and C-Reactive Protein Release After Elective Stenting: Results From the CLEAR PLATELETS 1b Study. Journal of the American College of Cardiology 2006;48:2186-2191. (Link)

Lekakis,J.P.; Vamvakou,G.; Andreadou,I.; Ganiatsos,G.; Karatzis,E.; Protogerou,A.; Papaioannou,T.; Ikonomidis,I.; Papamichael,C.; Mavrikakis,M.E.. Divergent effects of rofecoxib on endothelial function and inflammation in acute coronary syndromes. International Journal of Cardiology 2006;112:359-366. (Link)

Valable,Samuel; Montaner,Joan; Bellail,Anita; Berezowski,Vincent; Brillault,Julien; Cecchelli,Romeo; Divoux,Didier; MacKenzie,Eric; Bernaudin,Myriam; Roussel,Simon; Petit,Edwige. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab 2005;25:1491-1504. (Link)

Schonbeck,Uwe; Gerdes,Norbert; Varo,Nerea; Reynolds,Rebecca S.; Horton,Daniel B.; Bavendiek,Udo; Robbie,Linda; Ganz,Peter; Kinlay,Scott; Libby,Peter. Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells. Circulation 2002;106:2888-2893. (Link)

Brown,Vanessa; Elborn,J.Stuart; Bradley,Judy; Ennis,Madeleine. Dysregulated apoptosis and NFÝB expression in COPD subjects. Respiratory Research 2009;10:24-24. (Link)

Onder,Graziano; Capoluongo,Ettore; Cesari,Matteo; Lulli,Paola; Liperoti,Rosa; Giardina,Bruno; Russo,Andrea; Bernabei,Roberto; Landi,Francesco. Association of Calcium Channel Blocker Use and Pregnancy-Associated Plasma Protein-A Among Older Adults With Hypertension: Results From the ilSIRENTE Study. Journals of Gerontology Series A: Biological and Medical Sciences 2007;62:1274-1278. (Link)

Paczesny,Sophie; Krijanovski,Oleg I.; Braun,Thomas M.; Choi,Sung W.; Clouthier,Shawn G.; Kuick,Rork; Misek,David E.; Cooke,Kenneth R.; Kitko,Carrie L.; Weyand,Angela; Bickley,Daniel; Jones,Dawn; Whitfield,Joel; Reddy,Pavan; Levine,John E.; Hanash,Samir M.; Ferrara,James L.M.. A biomarker panel for acute graft-versus-host disease. Blood 2009;113:273-278. (Link)

Ko,Y.G.; Jung,J.H.; Park,S.; Choi,E.; Joung,B.; Hwang,K.C.; Ha,J.W.; Choi,D.; Jang,Y.; Chung,N.. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial... International Journal of Cardiology 2006;112:66-71. (Link)

Sorensen,C.M.; Hansen,T.K.; Steffensen,R.; Jensenius,J.C.; Thiel,S.. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clinical and Experimental Immunology 2006;145:173-182. (Link)

O'Kennedy,Niamh; Crosbie,Lynn; Whelan,Stuart; Luther,Vanessa; Horgan,Graham; Broom,John I.; Webb,David J.; Duttaroy,Asim K.. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. American Journal of Clinical Nutrition 2006;84:561-569. (Link)

Ceriello,Antonio; Assaloni,Roberta; Da Ros,Roberto; Maier,Amabile; Piconi,Ludovica; Quagliaro,Lisa; Esposito,Katherine; Giugliano,Dario. Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients. Circulation 2005;111:2518-2524. (Link)

Martina,Valentino; Masha,Andi; Gigliardi,Valentina Ramella; Brocato,Loredana; Manzato,Enzo; Berchio,Arrigo; Massarenti,Paola; Settanni,Fabio; Della Casa,Lara; Bergamini,Stefania; Iannone,Anna. Long-Term N-Acetylcysteine and L-Arginine Administration Reduces Endothelial Activation and Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2008;31:940-944. (Link)

References: van Leeuwen,M.A.; van Rijswijk,M.H.. Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin.Rheumatol. 1994;8:531-552. (Link)

Macy,E.M.; Hayes,T.E.; Tracy,R.P.. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin.Chem. 1997;43:52-58. (Link)

Uotila,M.; Ruoslahti,E.; Engvall,E.. Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J.Immunol.Methods 1981;42:11-15. (Link)

Lee,S.H.; Brennan,F.R.; Jacobs,J.J.; Urban,R.M.; Ragasa,D.R.; Glant,T.T.. Human monocyte/macrophage response to cobalt-chromium corrosion products and titanium particles in patients with total joint replacements. J.Orthop.Res. 1997;15:40-49. (Link)

Morley,J.J.; Kushner,I.. Serum C-reactive protein levels in disease. Ann.N.Y.Acad.Sci. 1982;389:406-418. (Link)

Ridker,P.M.; Glynn,R.J.; Hennekens,C.H.. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011. (Link)

Kushner,I.; Rzewnicki,D.L.. The acute phase response: general aspects. Baillieres Clin.Rheumatol. 1994;8:513-530. (Link)

Shine,B.; de Beer,F.C.; Pepys,M.B.. Solid phase radioimmunoassays for human C-reactive protein. Clin.Chim.Acta 1981;117:13-23. (Link)

Morley,J.J.; Kushner,I.. Serum C-reactive protein levels in disease. Ann.N Y.Acad.Sci. 1982;389:406-418. (Link)

Kushner,I.. C-reactive protein in rheumatology. Arthritis Rheum. 1991;34:1065-1068. (Link)

Schultz,D.R.; Arnold,P.I.. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin.Arthritis Rheum. 1990;20:129-147. (Link)

Tracy,R.P.; Lemaitre,R.N.; Psaty,B.M.; Ives,D.G.; Evans,R.W.; Cushman,M.; Meilahn,E.N.; Kuller,L.H.. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler.Thromb.Vasc.Biol. 1997;17:1121-1127. (Link)

View More Products

Antigens	Area of Biology	Formats
C-Reactive Protein (CRP)	Innate Immunity Metabolism	HRP